Market Tracker

07/29 4:53pm ET

Echo Therapeutics Inc (NASDAQ:ECTE)

2.05
Data as of 3:56pm ET
 -0.0146 / -0.71%
Today’s Change
1.53
Today|||52-Week Range
4.91
-34.86%
Year-to-Date
No recent news for Echo Therapeutics Inc.

Today’s Trading

Previous close2.06
Today’s open2.04
Day’s range2.01 - 2.08
Volume24,126
Average volume (3 months)98,171
Market cap$24.6M
Dividend yield--
Data as of 3:56pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)+24.84%
Earnings growth (this year)+62.45%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+439.17%
P/E ratioNM
Price/Sales951.08
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
HTBXHeat Biologics Inc+0.32+7.88%
PRPHProPhase Labs Inc-0.04-2.49%
RTGNRuthigen Inc+0.53+9.41%
--Matinas BioPharma Ho...+0.05+5.88%
Data as of 3:59pm ET, 07/29/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$27.6K
Annual profit (last year)-$19.1M
Net profit margin-69,084.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO, Secretary, Chief Compliance Officer &
SVP
Kimberly A. Burke
Senior Vice President-
Operations
Marshall D. Deweese
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts